≤90天婴儿SARS-CoV-2感染的表现与结局比较
这项国际多中心二次分析纳入1048例≤90天因疑似SARS-CoV-2感染就诊并检测的婴儿,其中432例(41.2%)阳性。阳性婴儿发热和上呼吸道症状更常见,但住院、重症监护和严重结局风险均低于阴性婴儿。
要点
- ≤90天婴儿中SARS-CoV-2阳性者发热和上呼吸道症状更常见。
- 阳性婴儿住院率32.9%低于阴性44.8%,重症监护1.4%低于5.0%。
- 严重结局阳性1.4%低于阴性5.4%,总体病情较轻。
核心结论
- ≤90天婴儿SARS-CoV-2感染与类似疾病难以区分,但病情通常较轻。
研究设计与样本
- 对41个全球儿科急诊网络和14个加拿大儿科急诊网络就诊的0-90天疑似SARS-CoV-2感染婴儿进行二次分析,检测采用分子方法并随访14天。
- 共纳入1048例婴儿,其中1007例(96.1%)就诊时有症状,432例(41.2%)SARS-CoV-2阳性。
主要发现
- 全身症状(呼吸暂停、嗜睡、易激惹或昏睡)最常见,646例(61.6%)存在,与SARS-CoV-2状态无关。
- SARS-CoV-2阳性婴儿发热和上呼吸道症状更常见,但脱水、胃肠道、皮肤和口腔症状及症状总数两组无差异。
- 阳性婴儿住院率32.9% vs 44.8%(差值-11.9%,95%CI -17.9%至-6.0%),重症监护1.4% vs 5.0%(差值-3.6%,95%CI -5.7%至-1.6%),严重结局1.4% vs 5.4%(差值-4.0%,95%CI -6.1%至-1.9%)。
临床怎么用
- SARS-CoV-2检测有助于指导≤90天婴儿的临床管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To compare symptoms and outcomes among infants aged ≤90 days tested for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a broad, international sample of emergency departments (EDs). METHODS: This was a secondary analysis of infants aged 0 to 90 days with suspected SARS-CoV-2 infections tested using molecular approaches and with 14-day follow-up. The parent studies were conducted at 41 EDs in 10 countries (the global Pediatric Emergency Research Network; March 2020-June 2021) and 14 EDs across Canada (Pediatric Emergency Research Canada network; August 2020-February 2022). Symptom profiles included presence and number of presenting symptoms. Clinical outcomes included hospitalization, ICU admission, and severe outcomes (a composite of intensive interventions, severe organ impairment, or death). RESULTS: Among 1048 infants tested for SARS-CoV-2, 1007 (96.1%) were symptomatic at presentation and 432 (41.2%) were SARS-CoV-2-positive. A systemic symptom (any of the following: Apnea, drowsiness, irritability, or lethargy) was most common and present in 646 (61.6%) infants, regardless of SARS-CoV-2 status. Although fever and upper respiratory symptoms were more common among SARS-CoV-2-positive infants, dehydration, gastrointestinal, skin, and oral symptoms, and the overall number of presenting symptoms did not differ between groups. Infants with SARS-CoV-2 infections were less likely to be hospitalized (32.9% vs 44.8%; difference -11.9% [95% confidence interval (CI) -17.9% to -6.0%]), require intensive care (1.4% vs 5.0%; difference -3.6% [95% CI -5.7% to -1.6%]), and experience severe outcomes (1.4% vs 5.4%; difference -4.0% [95% CI -6.1% to -1.9%]). CONCLUSIONS: SARS-CoV-2 infections may be difficult to differentiate from similar illnesses among the youngest infants but are generally milder. SARS-CoV-2 testing can help inform clinical management.
引用
- Burstein B, Sabhaney V, Florin TA, et al. Presentations and Outcomes Among Infants ≤90 Days With and Without SARS-CoV-2. Pediatrics. 2024. PMID: 38516718. doi:10.1542/peds.2023-064949
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。